JP2021535087A5 - - Google Patents

Info

Publication number
JP2021535087A5
JP2021535087A5 JP2021505981A JP2021505981A JP2021535087A5 JP 2021535087 A5 JP2021535087 A5 JP 2021535087A5 JP 2021505981 A JP2021505981 A JP 2021505981A JP 2021505981 A JP2021505981 A JP 2021505981A JP 2021535087 A5 JP2021535087 A5 JP 2021535087A5
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
fibrosis
cancer
Prior art date
Application number
JP2021505981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535087A (ja
JP7414803B2 (ja
JPWO2020024017A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2019/050811 external-priority patent/WO2020024017A1/en
Publication of JP2021535087A publication Critical patent/JP2021535087A/ja
Publication of JPWO2020024017A5 publication Critical patent/JPWO2020024017A5/ja
Publication of JP2021535087A5 publication Critical patent/JP2021535087A5/ja
Application granted granted Critical
Publication of JP7414803B2 publication Critical patent/JP7414803B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021505981A 2018-08-03 2019-08-02 リシルオキシダーゼのハロアリルアミンスルホン誘導体阻害剤およびそれらの使用 Active JP7414803B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018902829 2018-08-03
AU2018902829A AU2018902829A0 (en) 2018-08-03 Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof
PCT/AU2019/050811 WO2020024017A1 (en) 2018-08-03 2019-08-02 Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof

Publications (4)

Publication Number Publication Date
JP2021535087A JP2021535087A (ja) 2021-12-16
JPWO2020024017A5 JPWO2020024017A5 (https=) 2022-08-04
JP2021535087A5 true JP2021535087A5 (https=) 2022-08-04
JP7414803B2 JP7414803B2 (ja) 2024-01-16

Family

ID=69230421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505981A Active JP7414803B2 (ja) 2018-08-03 2019-08-02 リシルオキシダーゼのハロアリルアミンスルホン誘導体阻害剤およびそれらの使用

Country Status (13)

Country Link
US (2) US12178791B2 (https=)
EP (1) EP3829520B1 (https=)
JP (1) JP7414803B2 (https=)
KR (1) KR102780601B1 (https=)
CN (1) CN112533897B (https=)
AR (1) AR115906A1 (https=)
AU (1) AU2019315330B2 (https=)
CA (1) CA3105599A1 (https=)
ES (1) ES3010655T3 (https=)
MX (1) MX2021001347A (https=)
TW (1) TW202019877A (https=)
WO (1) WO2020024017A1 (https=)
ZA (1) ZA202100148B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020317374A1 (en) * 2019-07-25 2022-02-03 Pharmaxis Ltd. Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
US12578335B2 (en) * 2020-02-05 2026-03-17 Syntara Limited Bioprobes for lysyl oxidases and uses thereof
EP4173639A4 (en) * 2020-06-26 2024-03-13 RaQualia Pharma Inc. METHOD FOR SELECTING A CANCER PATIENT FOR WHICH COMBINATION THERAPY OF A RETINOID AND A CANCER TREATMENT AGENT WILL BE EFFECTIVE, AND COMBINATION DRUG OF A RETINOID AND A CANCER TREATMENT AGENT
US12233056B2 (en) * 2022-04-06 2025-02-25 Syntara Limited Lysyl oxidase inhibitors for treating myeloid malignancies
JP2025528475A (ja) * 2022-08-29 2025-08-28 シンタラ・リミテッド リシルオキシダーゼの新規選択的阻害剤
MA71743A (fr) * 2022-11-07 2025-05-30 Eisai R&D Management Co., Ltd. Procédé de production d'un composé macrolide

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28819E (en) 1972-12-08 1976-05-18 Syntex (U.S.A.) Inc. Dialkylated glycol compositions and medicament preparations containing same
US4358603A (en) 1981-04-16 1982-11-09 Syntex (U.S.A.) Inc. Acetal stabilized prostaglandin compositions
US4454158A (en) 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4699928A (en) 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
US4965288A (en) 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5182297A (en) 1988-02-25 1993-01-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5021456A (en) 1988-02-25 1991-06-04 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059714A (en) 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
DE10216144A1 (de) 2002-04-12 2003-11-06 Bayer Ag Substituierte 2-Phenyl-3(2H)-Pyridazinone
DE102004056226A1 (de) 2004-11-22 2006-05-24 Burchardt, Elmar Reinhold, Dr.Dr. Neuartige Inhibitoren der Lysyloxidase
US20080293969A1 (en) 2005-11-22 2008-11-27 Ge Healthcare Limited 18F-Labeled Daa Analogues and Method of Labeling These Analogues as Positron Emission Tomography (Pet) Tracers For Imaging Peripheral Benzodiazepine Receptors
WO2007120528A2 (en) 2006-03-31 2007-10-25 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
US20080293936A1 (en) 2007-05-23 2008-11-27 Elmar Reinhold Burchardt Novel inhibitors of lysyl oxidase
CA2693310C (en) 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
JP2011504485A (ja) 2007-11-21 2011-02-10 ファーマクシス リミテッド Ssao/vap−1のハロアリルアミン阻害剤およびその用途
WO2011022670A1 (en) 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vivo screening assays
EP3438087A1 (en) * 2012-05-02 2019-02-06 Boehringer Ingelheim International GmbH Substituted 3-haloallylamine inhibitors of ssao and uses thereof
WO2016144702A1 (en) 2015-03-06 2016-09-15 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
JP6697809B2 (ja) 2015-03-06 2020-05-27 ファーマケア,インク. フッ素化リシルオキシダーゼ様2阻害剤とその使用
EP3317258A4 (en) 2015-07-01 2019-06-26 Pharmakea, Inc. LYSYL OXIDASE LIKE 2 INHIBITORS AND USES THEREOF
US20180215727A1 (en) 2015-07-23 2018-08-02 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
JP6849197B2 (ja) 2016-02-12 2021-03-24 ファーマクシス リミテッド リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用
GB201602934D0 (en) 2016-02-19 2016-04-06 Cancer Res Inst Royal Compounds
WO2018048930A1 (en) 2016-09-07 2018-03-15 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
US20200069648A1 (en) * 2017-03-02 2020-03-05 Pharmaxis Ltd. Haloallylamine pyrazole derivative inhibitors of lysyl oxidases and uses thereof
GB201716871D0 (en) 2017-10-13 2017-11-29 Inst Of Cancer Research: Royal Cancer Hospital Compounds

Similar Documents

Publication Publication Date Title
JP2021535087A5 (https=)
JP2019504899A5 (https=)
JP2019504898A5 (https=)
JP2021073241A (ja) 癌を処置する方法
JP2017528467A5 (https=)
JP2012520861A5 (https=)
JP2014503574A5 (https=)
JP2017504576A5 (https=)
JP2009526072A5 (https=)
JP2017507122A5 (https=)
HRP20161547T1 (hr) Derivati 5-fluor-n-(piridin-2-il)piridin-2-amina koji sadrže sulfoksiminsku skupinu
JP2015522650A5 (https=)
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
JP2009536620A5 (https=)
JP2011513305A5 (https=)
JP2012512886A5 (https=)
JP2017132814A5 (https=)
JP2007504160A5 (https=)
JP2010526814A5 (https=)
JP2016520618A5 (https=)
JP2009544602A5 (https=)
JP2019507179A5 (https=)
JP2012523440A5 (https=)
JP2017508733A5 (https=)
JP2018048143A5 (https=)